January 7, 2025- When it comes to medical devices, having the right data can make or break a regulatory strategy. But for forward-thinking companies such as Teleflex, a global provider of medical technologies, collecting data is only the starting point.
Real-world data (RWD) has become central to regulatory strategy in the medical device and life sciences industries. However, the true value lies in transforming that data into structured, validated insights that meet the standards of global regulators, accelerate market access and keep patient safety front and center.
Working with Premier, Teleflex created an evidence set for a high-risk implantable device that is precise, traceable, clinically meaningful and fit for real-world decision-making.
Continue Reading here.